The Floow Limited has been acquired by Otonomo Technologies Ltd.
Direct Line Insurance Group plc has sold The Floow Limited, a software as a service (SaaS) global provider of connected insurance technology for major carriers, to Otonomo Technologies, the mobility intelligence company.
The Floow is a pioneer in the use of advanced data analytics that sits behind blue-chip insurers-connected automotive insurance policies that effectively prices on driving behavior and usage, rather than more typical demographics.
Located in Israel, Otonomo Technologies is a cloud-based SaaS platform for the vehicle data exchange.
Oaklins Cavendish, based in the UK, advised on the sale of The Floow Limited.
Aldo Monteforte
CEO, The Floow Limited
Sprechen Sie mit dem Deal Team
Transaktionen
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Mehr erfahrenFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Mehr erfahrenBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Mehr erfahren